Education
About Us
Working with TipRanks
Follow Us
Bio-Techne (TECH)
NASDAQ:TECH
Earnings Data
Report Date
Aug 12, 2025TBA Not Confirmed
Period Ending
2025 (Q4)Consensus EPS Forecast
0.52Last Year’s EPS
0.49Same Quarter Last Year
Moderate Buy
Based on 8 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:May 07, 2025
|% Change Since: 2.16%
|Next Earnings Date:Aug 12, 2025
Earnings Call Sentiment|Neutral
Bio-Techne reported strong organic revenue growth and a solid financial position with significant achievements in the pharma and diagnostics segments. However, challenges such as NIH funding uncertainty, tariff impacts, and difficulties in the China market present notable headwinds. The company's strategies to mitigate these challenges are promising, yet the timing and full impact remain uncertain.Company Guidance
During the third quarter of Fiscal Year 2025, Bio-Techne reported strong financial performance, with a 6% organic revenue growth and a 34.9% adjusted operating margin, despite a challenging macroeconomic environment. The company's growth was driven by low double-digit growth in the pharma sector, a 7% increase in the Protein Sciences segment, and a 2% growth in Diagnostics and Spatial Biology. The company also saw significant contributions from its GMP reagents, which grew at a high-single-digit rate, and its protein analytical instrumentation business. Bio-Techne's adjusted EPS rose to $0.56 from $0.48 in the previous year, with a GAAP EPS of $0.14. The company is strategically navigating challenges such as NIH funding uncertainties and tariff impacts, expecting full mitigation of tariff costs by the start of Fiscal Year 2026. Despite these challenges, Bio-Techne remains well-positioned for future growth, bolstered by its comprehensive product portfolio and strategic investments.Strong Organic Revenue Growth
Bio-Techne reported 6% organic revenue growth in a challenging macro environment, with a focus on profitability leading to an adjusted operating margin of 34.9%.
Pharma Segment Performance
The pharma segment showed low double-digit growth, driven by improved R&D pipelines and strong demand in the Protein Sciences segment with 7% organic revenue growth.
Protein Analytical Instrument Growth
The protein analytical instrumentation business, particularly the biologics platform Maurice, experienced double-digit growth driven by strong demand from pharma and CRO partners.
Diagnostics Growth
Year-to-date growth in diagnostic reagents was in the high-single digits, and the Asuragen portfolio saw low double-digit growth. The ExoDx prostate cancer test increased over 30% for the fiscal year-to-date.
Tariff Mitigation Strategies
Despite tariff challenges, Bio-Techne is well-positioned to mitigate impacts through optimization of global production and supply chain strategies, with expected full mitigation by the start of fiscal 2026.
Strong Financial Position
Bio-Techne reported $41.1 million in cash generated from operations, returned $12.6 million in dividends, and executed $100 million in stock buybacks. The company maintains a strong balance sheet with a total leverage ratio well below one time EBITDA.
---
TECH Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
TECH Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| May 07, 2025 | $47.72 | $48.75 | +2.16% |
| Feb 05, 2025 | $72.46 | $75.16 | +3.73% |
| Oct 30, 2024 | $70.58 | $75.85 | +7.47% |
| Aug 07, 2024 | $78.16 | $70.72 | -9.52% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does Bio-Techne (TECH) report earnings?
Bio-Techne (TECH) is schdueled to report earning on Aug 12, 2025, TBA Not Confirmed.
What is Bio-Techne (TECH) earnings time?
Bio-Techne (TECH) earnings time is at Aug 12, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is TECH EPS forecast?
TECH EPS forecast for the fiscal quarter 2025 (Q4) is 0.52.
---